SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-057439
Filing Date
2024-05-06
Accepted
2024-05-06 16:09:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2413526d1_424b3.htm 424B3 113225
2 GRAPHIC tm2412691d1_s3img01.jpg GRAPHIC 8046
  Complete submission text file 0001104659-24-057439.txt   125609
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-278959 | Film No.: 24917565
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)